Agency for Health Care Administration (AHCA), Medicaid, Providers, Service utilization, Children, Adults, Program evaluation, Data collection, Data analysis, Health Maintenance Organizations, Medicaid Managed Care, MediPass, Penetration, Services research, Serious mental illness, Atypical anti-psychotic (AAP) medication, Cost analysis, Cost of care
This study will examine differences in pharmaceutical utilization rates relative to financial risk arrangements of differing insurance plans. During the last four years we have noted consistent differences in utilization of expensive, psychotropic medications between individuals enrolled in Health Maintenance Organizations (HMOs), which are at financial risk for the provision of pharmaceuticals, and the MediPass program in which the state bears the risk of pharmacy expenses. Persons in HMOs had lower levels of utilization.
Was this content written or created while at USF?
Citation / Publisher Attribution
Statewide Penetration and Standard Costs of Psychotropic Medications, Agency for Health Care Administration Report Series, 45 p.
Scholar Commons Citation
Murrin, Mary R., "Statewide Penetration and Standard Costs of Psychotropic Medications" (2003). Mental Health Law & Policy Faculty Publications. 504.